Defining optimal perioperative analgesia in patients undergoing laparotomy for advanced gynecologic malignancy: A randomized controlled trial
Stuart A. Ostby(Mayo Clinic in Arizona), Sean C. Dowdy(Mayo Clinic), Peter Martin(Northwestern University), Deepa Maheswari Narasimhulu(Mayo Clinic), Gretchen Glaser(WinnMed), Bijan J. Borah(Mayo Clinic in Florida), William A. Cliby(Mayo Clinic in Arizona), Katherine W. Arendt(Mayo Clinic), Karen Ishitani(Mayo Clinic), Michelle A. O. Kinney(Mayo Clinic), Amanika Kumar(Mayo Clinic in Florida), James P. Moriarty(Mayo Clinic in Arizona), Carrie Langstraat(Mayo Clinic in Arizona), Maureen A. Lemens(Mayo Clinic), Jamie N. Bakkum‐Gamez(Mayo Clinic in Arizona)
Cited by 9
Related Papers
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
|New England Journal of Medicine|2014|1.1k
Overexpression of a kinase‐inactive ATR protein causes sensitivity to DNA‐damaging agents and defects in cell cycle checkpoints
|The EMBO Journal|1998|532
Integrated Molecular Characterization of Uterine Carcinosarcoma
|Cancer Cell|2017|449